# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Cantor Fitzgerald analyst Sarah James reiterates UnitedHealth Group (NYSE:UNH) with a Overweight and maintains $591 price ta...
UnitedHealth will remove AbbVie's Humira from its preferred drug lists by 2025, opting for lower-cost biosimilars like Amge...
- Reuters
- Reuters